Emily Hallas's profile photo

Emily Hallas

Washington, D.C., United States

Breaking News Reporter at Washington Examiner

Articles

  • 1 week ago | washingtonexaminer.com | Emily Hallas

    The fate of President Donald Trump‘s tariffs looks likely to end up before the Supreme Court after a dramatic 24 hours of rulings and appeals in multiple courts. On Wednesday evening, the U.S. Court for International Trade ruled Trump‘s sweeping tariffs policy was unconstitutional, but less than a day later the U.S. Court of Appeals for the Federal Circuit temporarily reinstated the tariffs.

  • 1 week ago | washingtonexaminer.com | Emily Hallas

    The White House is seeking to more than triple the number of daily arrests made by Immigration and Customs Enforcement as the Trump administration ups its efforts to deport illegal immigrants. The Department of Homeland Security’s overarching goal is to deport at least 1 million illegal immigrants by the end of President Donald Trump’s first year back in office. That number is nearly quadruple the migrants deported in fiscal 2024 during the Biden administration’s final year.

  • 1 week ago | washingtonexaminer.com | Emily Hallas

    Washington, D.C. Mayor Muriel Bowser’s latest budget proposal includes a provision to expand the ability of local police to assist with deportations, marking her latest shift away from the district’s sanctuary city policies. Inserted into Washington, D.C.’s 2026 budget proposal, released Tuesday, is a request to repeal a banning police from assisting federal immigration authorities in carrying out deportations.

  • 1 week ago | washingtonexaminer.com | Emily Hallas

    EXCLUSIVE — Rep. Mark Green (R-TN) on Thursday introduced legislation that seeks to increase accountability for vaccine manufacturers in the wake of allegations that such companies deliberately misled the public about the risks of COVID-19 vaccines. Green reintroduced the Vaccines In Trial And Liability Act, which would strip liability protections from any company found to have lied about vaccine trial data.

  • 1 week ago | washingtonexaminer.com | Emily Hallas

    The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine for humans. The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million award for an mRNA-based H5N1 avian influenza vaccine that HHS granted Moderna in July 2024.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →